Synergistic effects of short peptides and antibiotics against bacterial and fungal strains

There is a rising tide of concern about the antibiotic resistance issue. To reduce the possibility of antibiotic‐resistant infections, a new generation of antimicrobials must be developed. Antimicrobial peptides are potential alternatives to antibiotics that can be used alone or together with conventional antibiotics to combat antimicrobial resistance. In this work, lead compounds LP‐23, DP‐23, SA4, and SPO from previously published studies were synthesized by solid‐phase peptide synthesis and their antimicrobial evaluation was carried out against various bacterial and fungal strains. Peptide combinations with antibiotics were evaluated by using the checkerboard method and their minimal inhibitory concentration (MIC) in combination was calculated by using the fractional inhibitory concentration (FIC) index. Cytotoxicity evaluations of these peptides further confirmed their selectivity toward microbial cells. Based on the FIC values, LP‐23, DP‐23, and SPO demonstrated synergy in combination with gentamicin against a gentamicin‐resistant clinical isolate of Escherichia coli . For Staphylococcus aureus , Escherichia coli , and Salmonella typhimurium , seven combinations exhibited synergistic effects between peptide/peptoids and the tested antibiotics. Additionally, almost all the combinations of peptides/peptoids with amphotericin B and fluconazole also showed effective synergy against A spergillus niger and A spergillus flavus . The synergy found between LP‐23, DP‐23, SA4, and SPO with the selected antibiotics may have the potential to be used as a combination therapy against various microbial infections.